Lv1
20 积分 2025-01-12 加入
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
22天前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
1个月前
已完结
A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer
7个月前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
8个月前
已完结
Peripheral Neuropathy in Patients With Ovarian Cancer Administrating Poly ADP-Ribose Polymerase Inhibitors: A Real-World Study Based on Bayesian Disproportionality Analysis of the US Food and Drug Administration Adverse Event Reporting System
10个月前
已完结
Under-Reporting of Adverse Drug Reactions
11个月前
已完结
The evolving role of disproportionality analysis in pharmacovigilance
11个月前
已完结
Adverse cardiac events associated with antibody-drug conjugates in cancer patients: retrospective analysis of FAERS database and RCTs
11个月前
已完结
Approach to premenopausal osteoporosis
1年前
已关闭
Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan
1年前
已完结
皖公网安备34019202002308
